Advertisement

Impact of iodine concentration and iodine delivery rate on contrast enhancement in coronary CT angiography: a randomized multicenter trial (CT-CON)

  • Marco Rengo
  • Anoeshka Dharampal
  • Marisa Lubbers
  • Marc Kock
  • Joachim E. Wildberger
  • Marco Das
  • André Niezen
  • Fiek van Tilborg
  • Marcel Kofflard
  • Andrea Laghi
  • Gabriel Krestin
  • Koen NiemanEmail author
Cardiac
  • 122 Downloads

Abstract

Objective

To compare the effect of contrast medium iodine concentration on contrast enhancement, heart rate, and injection pressure when injected at a constant iodine delivery rate in coronary CT angiography (CTA).

Methods

One thousand twenty-four patients scheduled for coronary CTA were prospectively randomized to receive one of four contrast media: iopromide 300 mg I/ml, iohexol 350 mg I/ml, iopromide 370 mg I/ml, or iomeprol 400 mg I/ml. Contrast media were delivered at an equivalent iodine delivery rate of 2.0 g I/s. Intracoronary attenuation was measured and compared (per vessel and per segment). Heart rate before and after contrast media injection was documented. Injection pressure was recorded (n = 403) during contrast medium injection and compared between groups.

Results

Intracoronary attenuation values were similar for the different contrast groups. The mean attenuation over all segments ranged between 384 HU for 350 mg I/ml and 395 HU for 400 mg I/ml (p = 0.079). Dose-length product (p = 0.8424), signal-to-noise ratio (all p > 0.05), time to peak (p = 0.324), and changes in heart rate (p = 0.974) were comparable between groups. The peak pressures differed: 197.4 psi for 300 mg I/ml (viscosity 4.6 mPa s), 229.8 psi for 350 mg I/ml (10.4 mPa s), 216.1 psi for 370 mg I/ml (9.5 mPa s), and 243.7 psi for 400 mg I/ml (12.6 mPa s) (p < 0.0001).

Conclusion

Intravascular attenuation and changes in heart rate are independent of iodine concentration when contrast media are injected at the same iodine delivery rate. Differences in injection pressures are associated with the viscosity of the contrast media.

Key Points

• The contrast enhancement in coronary CT angiography is independent of the iodine concentration when contrast media are injected at body temperature (37 °C) with the same iodine delivery rate.

• Iodine concentration does not influence the change in heart rate when contrast media are injected at identical iodine delivery rates.

• For a fixed iodine delivery rate and contrast temperature, the viscosity of the contrast medium affects the injection pressure.

Keywords

Contrast media Computed tomography angiography Coronary disease Randomized controlled trial 

Abbreviations

AE

Adverse events

AHA

American Heart Association

ANOVA

Analysis of variance

BPM

Beats per minute

CTA

Computed tomography angiography

CX

Circumflex artery

DLP

Dose-length product

ECG

Electrocardiogram

HU

Hounsfield units

IDR

Iodine delivery rate

IQR

Interquartile range

LAD

Left anterior descending artery

LMCA

Left main coronary artery

MDRD

Modification of Diet in Renal Disease

RCA

Right coronary artery

ROI

Region of interest

SD

Standard deviation

SNR

Signal-to-noise ratio

Notes

Acknowledgements

Dr. Alexander Boreham (co.medical, Berlin, Germany) is acknowledged for medical writing.

Funding

This study has received unrestricted funding from Bayer (Germany).

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Koen Nieman.

Conflict of interest

Koen Nieman declared institutional research support from Siemens Healthineers, GE Healthcare, Bayer Healthcare, and Heartflow Inc.

Joachim E. Wildberger declared institutional research grants from AGFA Healthcare, Bayer Healthcare, GE Healthcare, Philips Healthcare, Siemens Healthcare, and Optimed as well as personal disclosures (Speaker’s bureau) from Bayer and Siemens.

Marco Das declared institutional research grants at the time of the study from Bayer Healthcare, Philips Healthcare, and Siemens Healthcare as well as personal disclosures (Speaker’s bureau) from Bayer and Siemens and Cook Medical.

Andrea Laghi declared personal disclosure (Speaker’s bureau) from Bayer, Bracco, GE Healthcare, Merck, and Bristol-Myers Squibb.

The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• prospective.

• randomized controlled trial.

• multicenter study.

References

  1. 1.
    Thomas DM, Divakaran S, Villines TC et al (2015) Management of coronary artery calcium and coronary CTA findings. Curr Cardiovasc Imaging Rep 8:18CrossRefGoogle Scholar
  2. 2.
    Mihl C, Kok M, Wildberger JE et al (2015) Coronary CT angiography using low concentrated contrast media injected with high flow rates: feasible in clinical practice. Eur J Radiol 84:2155–2160CrossRefGoogle Scholar
  3. 3.
    Park EA, Lee W, Park SJ, Kim YK, Hwang HY (2016) Influence of coronary artery diameter on intracoronary transluminal attenuation gradient during CT angiography. JACC Cardiovasc Imaging 9:1074–1083CrossRefGoogle Scholar
  4. 4.
    Kok M, Mihl C, Seehofnerova A et al (2015) Automated tube voltage selection for radiation dose reduction in CT angiography using different contrast media concentrations and a constant iodine delivery rate. AJR Am J Roentgenol 205:1332–1338CrossRefGoogle Scholar
  5. 5.
    Mihl C, Maas M, Turek J et al (2017) Contrast media administration in coronary computed tomography angiography - a systematic review. Rofo 189:312–325CrossRefGoogle Scholar
  6. 6.
    Bae KT (2010) Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology 256:32–61CrossRefGoogle Scholar
  7. 7.
    Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51:5–40CrossRefGoogle Scholar
  8. 8.
    Husmann L, Alkadhi H, Boehm T et al (2006) Influence of cardiac hemodynamic parameters on coronary artery opacification with 64-slice computed tomography. Eur Radiol 16:1111–1116CrossRefGoogle Scholar
  9. 9.
    Cademartiri F, Mollet NR, Lemos PA et al (2006) Higher intracoronary attenuation improves diagnostic accuracy in MDCT coronary angiography. AJR Am J Roentgenol 187:W430–W433CrossRefGoogle Scholar
  10. 10.
    Cademartiri F, de Monye C, Pugliese F et al (2006) High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400. Invest Radiol 41:349–353CrossRefGoogle Scholar
  11. 11.
    Bayer plc (2017) Summary of product characteristics Ultravist 300. Bayer plc, Reading, United Kingdom. Available via http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1529039209505.pdf. Accessed September 12 2018
  12. 12.
    GE Healthcare Inc. (2018) Prescribing information Omnipaque. GE Healthcare Inc. Available via https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018956s101lbl.pdf. Accessed September 12 2018
  13. 13.
    Bracco Imaging Deutschland GmbH (2018) Fachinformation [prescribing information] Iomeron. Bracco Imaging Deutschland GmbH, Koblenz, Germany. Available via https://imaging.bracco.com/sites/braccoimaging.com/files/technica_sheet_pdf/de-de-2018-04-24-spc-Imeron.pdf. Accessed August 22 2018
  14. 14.
    Becker CR, Vanzulli A, Fink C et al (2011) Multicenter comparison of high concentration contrast agent iomeprol-400 with iso-osmolar iodixanol-320: contrast enhancement and heart rate variation in coronary dual-source computed tomographic angiography. Invest Radiol 46:457–464CrossRefGoogle Scholar
  15. 15.
    Mihl C, Wildberger JE, Jurencak T et al (2013) Intravascular enhancement with identical iodine delivery rate using different iodine contrast media in a circulation phantom. Invest Radiol 48:813–818CrossRefGoogle Scholar
  16. 16.
    Kok M, Mihl C, Hendriks BM et al (2016) Patient comfort during contrast media injection in coronary computed tomographic angiography using varying contrast media concentrations and flow rates: results from the EICAR trial. Invest Radiol 51:810–815CrossRefGoogle Scholar
  17. 17.
    Lubbers MM, Kock M, Niezen A et al (2018) Iodixanol versus Iopromide at coronary CT angiography: lumen opacification and effect on heart rhythm-the randomized IsoCOR trial. Radiology 286:71–80CrossRefGoogle Scholar
  18. 18.
    Zhang J, Fletcher JG, Harmsen WS et al (2008) Analysis of heart rate and heart rate variation during cardiac CT examinations. Acad Radiol 15:40–48CrossRefGoogle Scholar
  19. 19.
    Chartrand-Lefebvre C, White CS, Bhalla S et al (2011) Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study. Radiology 258:930–937CrossRefGoogle Scholar
  20. 20.
    Svensson A, Ripsweden J, Ruck A, Aspelin P, Cederlund K, Brismar BT (2010) Heart rate variability and heat sensation during CT coronary angiography: low-osmolar versus iso-osmolar contrast media. Acta Radiol 51:722–726CrossRefGoogle Scholar
  21. 21.
    Davenport MS, Wang CL, Bashir MR, Neville AM, Paulson EK (2012) Rate of contrast material extravasations and allergic-like reactions: effect of extrinsic warming of low-osmolality iodinated CT contrast material to 37 degrees C. Radiology 262:475–484CrossRefGoogle Scholar
  22. 22.
    Rutten A, Meijs MF, de Vos AM, Seidensticker PR, Prokop M (2010) Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose. Eur Radiol 20:1917–1925CrossRefGoogle Scholar
  23. 23.
    Jost G, Pietsch H, Sommer J et al (2009) Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Invest Radiol 44:114–123CrossRefGoogle Scholar
  24. 24.
    Kok M, Mihl C, Mingels AA et al (2014) Influence of contrast media viscosity and temperature on injection pressure in computed tomographic angiography: a phantom study. Invest Radiol 49:217–223CrossRefGoogle Scholar
  25. 25.
    Matsumoto Y, Higaki T, Masuda T et al (2018) Minimizing individual variations in arterial enhancement on coronary CT angiographs using “contrast enhancement optimizer”: a prospective randomized single-center study. Eur Radiol.  https://doi.org/10.1007/s00330-018-5823-2

Copyright information

© European Society of Radiology 2019

Authors and Affiliations

  • Marco Rengo
    • 1
  • Anoeshka Dharampal
    • 2
  • Marisa Lubbers
    • 2
  • Marc Kock
    • 3
  • Joachim E. Wildberger
    • 4
  • Marco Das
    • 4
  • André Niezen
    • 5
  • Fiek van Tilborg
    • 6
  • Marcel Kofflard
    • 7
  • Andrea Laghi
    • 8
  • Gabriel Krestin
    • 9
  • Koen Nieman
    • 2
    • 10
    Email author
  1. 1.Faculty of Pharmacy and MedicineUniversity of Rome SapienzaLatinaItaly
  2. 2.Departments of Radiology and CardiologyErasmus University Medical CenterRotterdamThe Netherlands
  3. 3.Department of RadiologyAlbert Schweitzer ZiekenhuisDordrechtthe Netherlands
  4. 4.Department of Radiology and Nuclear MedicineMaastricht UMC+Maastrichtthe Netherlands
  5. 5.Department of Radiology and Nuclear medicineMaasstad ZiekenhuisRotterdamthe Netherlands
  6. 6.Department of RadiologyElisabeth-TweeSteden ZiekenhuisTilburgThe Netherlands
  7. 7.Department of CardiologyAlbert Schweitzer ZiekenhuisDordrechtthe Netherlands
  8. 8.Department of Surgical and Medical Sciences and Translational MedicineUniversity of Rome SapienzaRomeItaly
  9. 9.Department of RadiologyErasmus University Medical CenterRotterdamThe Netherlands
  10. 10.Stanford University School of Medicine and Cardiovascular InstituteStanfordUSA

Personalised recommendations